Gateway to Translation Webinar: BIOINX
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester).
The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors. Recordings from previous webinars are available here.
The September 2025 webinar of this series, hosted by Translation Manchester, was on Tuesday 30th September from 2-3 pm (via Zoom). Our guest speaker, Dr Jasper Van Hoorick, CEO of BIO INX BV, guided us through the exciting recent progress in 3D printing of tissues and organs. This event was chaired by Prof Athina Markaki, Professor of Materials and Biomedical Engineering, University of Cambridge. Jasper brings expertise in polymer chemistry and biofabrication, with a passion for advancing tissue engineering and regenerative medicine. Discover how cutting-edge bioinks are paving the way toward functional human tissues, and even organs, for research and therapeutic applications.
Topic: “En Route to 3D Printed Organs: the Role of Bio inks”
Guest Speaker: Dr Jasper Van Hoorick, CEO of BIO INX BV.
Date and Time: Tuesday, 30th September, from 2-3 pm
Click to learn more about the speaker
Jasper Van Hoorick is a Belgian chemist and innovator who leads BIO INX, a Ghent‑based biotech startup specialising in advanced bioinks for 3D bioprinting. He focused his PhD research on biodegradable polymers and multiphoton lithography for ocular tissue regeneration, for which he earned his doctorate summa cum laude from Ghent University and VUB for which he was awarded the Agoria (2014), Solvay (2019) and Julia Polak Awards (2020). He co-authored over 30 peer reviewed publications in the field of 3D bioprinting and has a H-index of 24 (Google Scholar). In 2022, he spun out BIO INX from the research group of Professor Sandra Van Vlierberghe together with, among others, Aysu Arslan (CSO), drawing on their polymer chemistry expertise to develop high‑precision bioinks for tissue engineering and drug-testing applications.
Jasper’s ambition goes beyond replacing animal testing—he hopes to advance to bioprinting functional human tissues, even organs for space research and regenerative medicine. Under his leadership, BIO INX is now a global player in biofabrication materials, continuing to partner on cutting-edge research and the commercialisation of next-generation bioinks
Click to learn more about the Company
BIO INX® is a spin-off company of Ghent University and Vrije Universiteit Brussel focusing on the commercialisation of materials and bio-inks for 3D bioprinting or biofabrication by utilizing decades of academic experience in the field of polymers and biomaterials. By offering a unique material portfolio with a diverse range of material properties, the applications become nearly limitless: the bio-inks can be applied for various tissue types with applications in regenerative medicine and drug and cosmetics screening. Additionally, by offering a bio-ink portfolio suitable for multiple printing technologies, attainable resolutions range from hundreds of micrometers to hundreds of nanometers.
Our multidisciplinary team with backgrounds in chemistry and biomedical engineering has a combined 20 years of expertise in the field of polymers, (bio)materials, 3D printing and tissue engineering. Therefore we can provide you with the best possible solutions for all your biofabrication needs.
Watch a recording from the event below:
Contact Us
Email:
0 Comments